Probiotic

Fecal microbiota transplantation was safe and effective for the treatment of Clostridioides difficile infection in patients with cirrhosis, according to study results.

Patients on peritoneal dialysis who received daily probiotic supplementation saw improvements in measures related to malnutrition and health-related quality of life, according to results of a randomized controlled trial conducted in China.

Combination of Lactobacillus and Bifidobacterium were superior to single- and other multiple-strain probiotics and helped reduced all-cause mortality in preterm, low-birthweight infants, according to a meta-analysis published in Gastroenterology.

Healio Gastroenterology presents the following reports on the most recent research on inflammatory bowel disease.

The American Gastroenterological Association issued new guidance that recommends against the use of probiotics for digestive conditions. It was the top story in gastroenterology last week.

In newly issued guidelines, the American Gastroenterological Association did not recommend using probiotics for most digestive conditions.

The intrigue surrounding the use of fecal microbiota transplantation to treat various gastrointestinal disorders and infections has intensified over the last several years.

Intake of a multistrain probiotic improved cognitive function, risk for falls and inflammatory response in patients with cirrhosis and a history of cognitive impairment and previous falls, according to a study published in Hepatology Communications.

POINT

SAN FRANCISCO — A genetic analysis of Bacillus strains found in probiotic products that researchers purchased at a supermarket showed that some are resistant to antibiotics, according to data presented at ASM Microbe.